Searchable abstracts of presentations at key conferences on calcified tissues

ba0006p135 | (1) | ICCBH2017

Continuous subcutaneous PTH infusion in autosomal dominant hypocalcaemia

Gevers Evelien , Buck Jacqui , Ashman Neil , Thakker Rajesh , Allgrove Jeremy

Objectives: Autosomal Dominant Hypocalcaemia (ADH) is due to gain-of-function mutations of the CASR resulting in constitutive activation of the GPCR Calcium Sensing Receptor (CaSR) leading to hypercalciuric hypocalcaemia, hypoparathyroidism and occasionally Bartter syndrome type V. Patients usually present with hypocalcaemic seizures at young age. Conventional treatment is with Alfacalcidol and Calcium or PTH injections. We describe a series of five patients with ADH ...

ba0006p153 | (1) | ICCBH2017

Vitamin D intake and status in children 2–18 years: a meta-analysis

Brett Neil , Weiler Hope

Evidence is unclear on the effect of vitamin D intake on vitamin D status in children.Objective: In a meta-analysis, investigate the effect of vitamin D supplements and/or fortified foods on vitamin D status, using the biomarker 25-hydroxyvitamin D (25(OH)D) in children 2–18 years.Methods: Eligible studies were randomized placebo-controlled trials, published in English, in children 2–18 years that compared vitamin D suppl...

ba0003pp166 | Cell biology: osteoclasts and bone resorption | ECTS2014

Functional read out of perturbed osteoclast behaviour in an in vitro model of Gaucher's disease

Nijjar Sarbjit , Gittoes Neil , Geberhiwot Tarekegn

Gaucher’s disease is a glycolipid storage disorder caused by an autosomally inherited deficiency of the lysosomal enzyme glucocerebrosidase. The majority of patients with Gaucher’s disease develop abnormal bone remodelling with severe consequences, including osteonecrosis, bone crises, and osteoporosis related fractures. Although enzyme replacement therapy is effective at reversing many of the pathological consequences, and preventing further progression of this dise...

ba0004p92 | (1) | ICCBH2015

Risedronate in the treatment of children with osteogenesis imperfecta: retrospective review of practice and outcomes at a large paediatric metabolic bone unit

Lawrence Neil , Bishop Nick , Arundel Paul

Objectives and method: We retrospectively reviewed records of current patients with osteogenesis imperfecta (OI) to identify those on risedronate, doses used and effects of treatment. BMD changes over time were calculated as difference between measurement before risedronate and at one year (including measurements −3–0 m and 10–14 m after starting risedronate respectively).Results: 219/296 (74%) patients with OI had received bisphosphonate...

ba0006oc6 | (1) | ICCBH2017

Lean mass accretion increases during summer and positively associates with vitamin D status in healthy children 2-8 years

Brett Neil , Vanstone Catherine , Weiler Hope

The relationship between vitamin D status and lean mass accretion in young children is not well understood.Objective: To explore vitamin D status in relation to lean mass outcomes over 12 mo in children 2–8 years.Methods: This was a secondary analysis of trial data (clinicaltrials.gov: NCT02097160, NCT02387892) in Montreal, Canada. Children consumed their normal vitamin D intake for 6 mo (Apr–Oct 2014, n=39) and ...

ba0006p140 | (1) | ICCBH2017

Bone mineral accretion is increased during winter and is positively related to lean mass accretion in healthy children 2--8 years

Brett Neil , Vanstone Catherine , Weiler Hope

In children, it is not well understood how bone mineral accretion is related to lean mass accretion and vitamin D status.Objective: To explore over 12 mo how bone parameters relate to lean mass and vitamin D metabolites in children 2–8 years.Methods: This was a secondary analysis of data from 2 trials (clinicaltrials.gov: NCT02097160, NCT02387892) in Montreal, Canada. Children consumed their normal diet without vitamin D suppl...

ba0001pp494 | Other diseases of bone and mineral metabolism | ECTS2013

BMP-9 induces the calcification of vascular smooth muscle cells

Zhu Dongxing , Mackenzie Neil , Farquharson Colin , MacRae Vicky

The process of vascular calcification shares many similarities with that of skeletal mineralisation, and involves the deposition of hydroxyapatite crystals in arteries and cardiac muscle. However, the cellular mechanisms responsible have yet to be fully elucidated. BMP-9 has been shown to exert direct effects on both bone development and vascular function. In the present study, we have investigated the role of BMP-9 in vascular smooth muscle cell (VSMC) calcification. Murine V...

ba0001pp496 | Other diseases of bone and mineral metabolism | ECTS2013

The miR-221/222 family regulates vascular smooth muscle cell calcification

Mackenzie Neil , Zhu Dongxing , Genever Paul , MacRae Vicky

The process of vascular calcification shares many similarities with that of skeletal mineralisation, and involves the phenotypic trans-differentiation of vascular smooth muscle cells (VSMCs) to osteoblastic and chondrocytic cells within a calcified environment. Various microRNAs (miRs) are known to regulate cell differentiation, however their role in mediating VSMC calcification has yet to be fully understood.Murine VSMCs were cultured for up to 28 days ...

ba0001oc6.5 | Mineralisation and energy metabolism | ECTS2013

A protective role for FGF23 in local defence against disrupted arterial wall integrity?

Zhu Dongxing , Mackenzie Neil , Millan Jose Luis , Farquharson Colin , MacRae Vicky

Increasing interest is focusing on the role of the FGF-23/Klotho axis in mediating vascular calcification. However, the underpinning mechanisms have yet to be fully elucidated. Murine VSMCs were cultured in calcifying medium for a 21-day period. FGF-23 mRNA expression was significantly up-regulated by 7 days (1.63-fold; P<0.001), with a concomitant increase in protein expression. mRNA and protein expression of both FGFR1 and Klotho were confirmed. Increased FGF-23...